Methods of use and pharmaceutical combinations comprising histone deacetylase inhibitors and JAK1/2 inhibitors
Abstract:
The disclosure relates to pharmaceutical combinations comprising an HDAC6 selective inhibitor and a JAK1/2 inhibitor for the treatment of a cancer, such as a hematological cancer, in a subject in need thereof. Also provided herein are methods for treating a cancer in a subject in need thereof, comprising administering to the subject an effective amount of an HDAC6 selective inhibitor and a JAK1/2 inhibitor.
Information query
Patent Agency Ranking
0/0